EXOSENS EXENS.PA · Stock Open EXOSENS in new tab
Analyst price targets
Recent rating changes, newest first
EXOSENS Analysis (EXENS.PA)
Is EXOSENS a good investment? EXOSENS (EXENS.PA) is currently trading at 58.40 EUR. Market analysts have a consensus price target of 69.70 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 139.05. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: EXOSENS is expected to release its next earnings report on July 28, 2026. The market consensus estimate for Forward EPS is 2.42.
For income investors, EXOSENS pays a dividend yield of 0.52%. With a payout ratio of 26%, the dividend appears sustainable.
Investor FAQ
Does EXOSENS pay a dividend?
Yes, it pays an annual dividend of 0.30 EUR (0.52% yield).
What asset class is EXOSENS?
EXOSENS is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 28, 2026. The company currently has a trailing EPS of 0.42.
Company Profile
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.30 EUR
|
| May 31, 2027 (estimated) | 0.3000 |
| ▸2026 |
0.30 EUR
|
| May 29, 2026 | 0.3000 |
| ▸2025 |
0.10 EUR
|
| May 30, 2025 | 0.1000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| EXOSENS | May 29, 2026 | Paid | 0.3 EUR |
Community Discussion